Blocking the PD-1/PD-L1 pathway can result in different degrees of inflammatory lesions in the colon, whereas PD-L1 administration can relieve symptoms of enteritis in dextran sulfate sodium (DSS)-induced colitis mice15–19. Here, CD274 is linked to colitis.